Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Trastuzumab Emtansine for Previously Treated HER2+ mBC"
By
Insights from 2023 SABCS
FEATURING
Sara A. Hurvitz
By
Insights from 2023 SABCS
FEATURING
Sara A. Hurvitz
348 views
December 12, 2023
Comments 0
Login to view comments.
Click here to Login
Videos